相关实验视频

Updated: Sep 18, 2025

Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples

Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples

Published on: January 7, 2019

人类恶性瘤中IFIT蛋白的临床实用性

Armen Parsyan^1,2,3,4, Arpitha Kochiyanil⁵, Anne C Bonvissuto^1,2

¹Department of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada.

|June 26, 2025

概括

干扰素 (IFN) 诱导的蛋白质与四基重复 (IFIT) 在免疫和癌症中至关重要. IFITs在瘤发生过程中发挥了双重作用,并且是癌症治疗结果的有希望的生物标志物.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

干扰素 (IFN) 诱导的蛋白质与四基重复 (IFIT) 是关键的干扰素刺激基因 (ISG).
IFITs主要是因为它们在对病原体的先天免疫反应中的作用而被认可.
新出现的证据表明,IFIT与各种细胞过程有关,包括癌症的发展和进展.

研究的目的:

审查目前对IFIT蛋白在癌症中的参与的理解.
突出IFIT作为瘤学中临床相关生物标志物的新兴角色.

主要方法:

关于癌症中的IFIT蛋白质研究的文献综述.
分析IFIT表达模式及其与临床结果的相关性.
关于IFITs在瘤发生中的双重功能的证据综合.

主要成果:

根据癌症类型,IFITs在瘤发生过程中表现出双重功能,根据癌症类型起到促瘤或瘤抑制作用.
异常的IFIT表达与各种癌症的患者存活率和临床结果相关.
IFIT与治疗耐药性有关,包括放射治疗,化疗,向治疗和免疫治疗.
IFIT是癌症治疗反应预测模型的组成部分.

结论:

IFIT蛋白在癌症的发展和进展中起着复杂的作用.
IFITs在瘤发生中的双重功能为我们提供了关于其致癌或瘤抑制活动的见解.
IFITs代表了有前途的临床生物标志物,用于预测患者的结果和指导癌症治疗.

关键词:

如果IFIT1是IFIT1,那么IFIT1是什么?在IFIT2的基础上,IFIT2是IFIT2的基础.在IFIT3中,IFIT3是IFIT3.如果IFIT5是IFIT5,那么IFIT5是什么?生物标志物生物标志物癌症癌症癌症癌症癌症干扰素诱导的蛋白质与四基重复.

更多相关视频

High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research

High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research

Published on: June 10, 2025

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...